{image_1}Dr. Patrick J. Flynn was selected by the Twin Cities Medical society Foundation Board as this recipient of the 2016 Charles Bolles Bolles-Rogers Award. Dr. P.J. Flynn was nominated by Dr. Joseph Leach on behalf of his colleagues at Minnesota Oncology.
Candidates for this "Physician of Excellence" award are nominated by their colleagues at Twin City area hospitals and/or clinics for achievement or leadership in medicine, contributions to clinical care, teaching and/or research. This candidate is considered to be an outstanding physician by his or her peers.
In a letter to Dr. Flynn notifying him of the award, Twin Cities Medical Society Foundation Chair Chris Johnson, M.D. and Twin Cities Medical Society CEO Sue Schettle noted: "Twin Cities Medical Society Foundation considers this award to be the single, most prestigious local honor that can be given to a physician by their colleagues."
Dr. P.J. Flynn's honor was recognized at the October Minnesota Oncology Board meeting, and the Award will be officially presented to Dr. Flynn in November at a physician event.
"We congratulate P.J. on this honor in observance of his excellent clinical care and outstanding leadership with cancer research in the Twin Cities over many years," said Minnesota Oncology President Dean Gesme, M.D.
Minnesota Oncology physicians Joseph Cardamone, M.D. and Burton Schwartz, M.D. are previous Bolles-Rogers Awardees.
Share
Categories
Tags
Recent Posts
If you don’t smoke, you’ve eliminated one of the biggest risk factors for developing lung cancer. But in the United States, about 10% to 20% of lung cancer diagnoses happen in people who have never smoked or have smoked fewer than 100 cigarettes in their lifetime.
Minnesota Oncology Warns Against Vaping During Lung Cancer Awareness Month
Biomarkers are proteins, hormones, or pieces of DNA that can be released by cancer cells or by your body in response to cancer.